United States · FDA National Drug Code directory
Pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-466_a59cea51-015e-4eb2-bdd0-08fa82f32f75
- Product NDC
- 67877-466
- Form
- CAPSULE
- Composition / generic term
- Pregabalin
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190721
- Source listing expiry
- 20271231
Source-listed ingredients
- PREGABALIN — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (67877-466-05) · 67877-466-05
- 30 CAPSULE in 1 BOTTLE (67877-466-30) · 67877-466-30
- 1 BLISTER PACK in 1 CARTON (67877-466-33) / 10 CAPSULE in 1 BLISTER PACK · 67877-466-33
- 10 BLISTER PACK in 1 CARTON (67877-466-38) / 10 CAPSULE in 1 BLISTER PACK · 67877-466-38
- 90 CAPSULE in 1 BOTTLE (67877-466-90) · 67877-466-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →